CapeStart

Scientific Research

As part of CapeStart's work with the life science industry's top innovators, we regularly co-author scientific research published in leading clinical journals and at industry conferences. This section shares those publications.

  1. European Urology Focus Research Sponsor: Bayer

    Real-World Treatment Patterns and Survival in Metastatic Castration-resistant Prostate Cancer: A Systematic Review of Observational Studies

    November 19, 2025 Scientific Research Amit D. Raval

    Treatment options have evolved for metastatic castration-resistant prostate cancer (mCRPC). The aim of our study was to examine real-world (RW) treatment patterns and survival for individuals with mCRPC via a systematic literature review of RW observational studies.

    Read the Publication
  2. ASCO Publications Research Sponsor: Bayer

    Treatment Patterns and Survival in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Literature Review of 35 Real-World Observational Studies.

    February 18, 2025 Scientific Research Amit D. Raval

    Treatment landscapes have changed dramatically in prostate cancer in the past decade. Therapies like androgen receptor pathways inhibitors (ARPIs), which were initially approved for mCRPC are now approved in the earlier disease spectrum, including biochemical recurrence (BCR), non-metastatic castration-resistant prostate cancer (nmCRPC), and hormone-sensitive metastatic prostate cancer (mHSPC).

    Read the Publication
  3. Value in Health Research Sponsor: CSL Behring

    Insights Into the Burden and Unmet Needs of Patients With Hereditary Angioedema: A Retrospective Social Media Listening Study

    December 14, 2024 Scientific Research J. Braverman

    Hereditary angioedema (HAE) is a rare genetic disease characterized by recurrent, painful, unpredictable, and debilitating attacks of angioedema which are detrimental to patients’ quality of life. Understanding the experience of patients living with HAE and existing unmet medical needs is critical for HAE management optimization.

    Read the Publication
  4. Value in Health Research Sponsor: Roche

    How Can Explainable Artificial Intelligence Accelerate the Systematic Literature Review Process?

    June 2, 2023 Scientific Research S. Abogunrin

    Systematic literature reviews (SLRs) are key evidence requirements for health technology agency decision-making. However, the exponential increase in published articles makes a thorough and practical literature review increasingly challenging. To help researchers conduct an SLR, we developed a machine learning (ML)-based pipeline to accelerate the title and abstract screening (TIABS) step. We assessed this ML-based…

    Read the Publication
  5. Value in Health Research Sponsor: Roche

    Training Models for Machine-Enabled Systematic Literature Reviews: Do Large Datasets Always Give Better Results?

    December 17, 2022 Scientific Research S. Abogunrin

    Artificial intelligence (AI) model fitting by supervised learning suggests that larger training datasets tend to produce more accurate predictions. This can be demonstrated by evaluating the final tuned model on a labeled test dataset. However, it is not clear what the minimum number of records is for training such models and whether larger training datasets…

    Read the Publication